Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Photodiagnosis Photodyn Ther ; 37: 102678, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1562141

ABSTRACT

Opportunistic infections are widely described in patients with novel coronavirus disease 2019 (COVID-19); however, very few studies have addressed those affecting the oral cavity. Given the lack of information on the clinical presentations and the available treatment options, the present study aimed to show a case in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for the management of two concomitant COVID-19-associated opportunistic oral infections (oral pseudomembranous candidiasis and recurrent herpes labialis). Within 7 days and without any systemic drug administration, all the lesions resolved completely, and the patient no longer reported oral pain or discomfort. According to the current case report and taking into consideration the significant gaps in the knowledge and understanding of COVID-19, this combination of phototherapy modalities seems to be a promising tool for managing viral and fungal opportunistic oral infections.


Subject(s)
COVID-19 , Opportunistic Infections , Photochemotherapy , Humans , Opportunistic Infections/drug therapy , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , SARS-CoV-2
2.
Photodiagnosis Photodyn Ther ; 37: 102643, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1531705

ABSTRACT

BACKGROUND AND AIM: Among the most common symptoms of COVID-19 is taste dysfunction, which has a ranging clinical presentation. As well as its pathophysiology remains to be unclear, there is not enough information about the efficacy and safety of the available treatments. This study aims to report a series of cases using PBMT for the management of COVID-19-related taste impairment. CASE SERIES: 8 female and 2 male patients sought medical help for taste impairment (either partially or completely) after COVID-19 infection. Photobiomodulation therapy (PBMT) on the tongue mucosa was then proposed but with 3 different protocols. Taste perception at baseline and before every laser session was evaluated using a visual analog scale. Irrespective of the PBMT protocol, taste recovery was noted in all cases but with varying degrees of improvement. CONCLUSION: given the high prevalence rates of taste dysfunction in COVID-19 patients and the lack of information about the available treatments, PBMT seems to be a promising therapeutic modality but not dependent on the total number of laser sessions and the interval between them. The choice of the most suitable laser protocol as well as the knowledge of the exact photonic mechanisms, however, need to be better studied.


Subject(s)
COVID-19 , Low-Level Light Therapy , Photochemotherapy , Female , Humans , Low-Level Light Therapy/methods , Male , Photochemotherapy/methods , SARS-CoV-2 , Taste Disorders/etiology
SELECTION OF CITATIONS
SEARCH DETAIL